These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2006-002933-18 Multizentrische, randomisierte, doppelblinde, placebokontrollierte Phase III-Studie zur (Langzeit-) Add On-Behandlung der COPD (Schweregrad III/IV) mit 2 x 80 mg inhalativem Tobramycin (Gernebcin) 2011-06-28 due-trials
Not reported 2006-004233-15 Multicentric, randomized, double-blinded, vehicle-controlled, phase III-bilateral comparative study for treatment of staphylococcus superinfection in atopic dermatitis with hydrophobic Triclosan-cream... 2009-05-19 due-trials
Not reported 2010-019754-41 Multizentrische, prospektive, einarmige Phase III-Studie zur Wirksamkeit und Sicherheit einer oralen Therapie mit Propranolol (ProAngiol Saft; 2 mg/kg KG/d mit fakultativer Dosiserhöhung auf 3 mg/kg K... 2011-09-15 due-trials
Not reported 2010-023566-43 Multizentrische, randomisierte, doppelblinde, kontrollierte Phase III-Studie zur Behandlung der papulopustulären Rosazea mit Permethrin Creme 5 % (InfectoScab®) versus Permethrin Creme 2,5 % versus Me... 2013-02-27 due-trials
Not reported 2011-002001-30 Multicenter, prospective, double-blind, two-armed phase III study for efficacy and safety of the topic impetigo therapy of two 2 % mupirocin ointments 2012-06-07 due-trials
Not reported 2012-002291-13 Multicentre, prospective, double-blind, two-armed, placebo-controlled phase III study to evaluate the efficacy and safety of the treatment of diarrhoea with Lactobacillus rhamnosus GG (InfectoDiarrsto... 2013-11-25 due-trials
Exempt Terminated 2014-003151-62 A randomised, two-period two-stage cross-over study on the relative bioavailability of two different formulations of single doses of noscapine (phase I/IV, open-label) in healthy volunteers (fasted st... 2015-01-30 not-yet-due
Completed, but no date Terminated 2016-002823-27 Placebo-kontrollierte, multizentrische, randomisierte, doppelblinde Phase III-Studie zur Verbesserung der gastrointestinalen Verträglichkeit einer per-oralen Antibiotikatherapie durch add-on-Gabe von ... bad-data